Skip to content

BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery

BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06722196
Acronym
BEAT-AF
Enrollment
500
Registered
2024-12-09
Start date
2025-02-15
Completion date
2027-12-15
Last updated
2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF)

Brief summary

The primary objective of the present prospective, randomized, double blind, controlled study is to assess whether the application of 2 oxidized regenerated cellulose (SurgicelTM FibrillarTM) patches soaked with amiodarone hydrochloride over the anterior wall of the left atrium and the lateral wall of the right atrium results in a reduction in the incidence of POAF

Interventions

DRUGtopical amiodarone

amiodarone soaked patch placed on the left atrial roof at the end of surgery

OTHERsaline solution patch

saline solution soaked patch placed on left atrial roof at the end of surgery

Sponsors

Cornell University
CollaboratorOTHER
Jilin Heart Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients who are candidates for elective cardiac surgery trough complete sternotomy with indications of coronary artery disease (both off-pump and on-pump), aortic valve disease, mitral valve disease, tricuspid valve disease, and ascending aorta disease, whether as an isolated pathology or in combination

Exclusion criteria

* patients with a clinical history of atrial or ventricular arrhythmia of any nature and duration, patients undergoing reoperation, patients with emergency surgical indications due to acute myocardial infarction or cardiogenic shock, patients with thyroid disfunction, patients with HOCM and those with pacemakers or ICDs

Design outcomes

Primary

MeasureTime frameDescription
postoperative atrial fibrillation versus controlwithin 5 days after surgeryincidence of in-hospital atrial fibrillation

Countries

China

Contacts

Primary ContactXin Lu
xin.lu@jlheart.org+86 13630550809
Backup ContactSui C Yu
chunyu.sui@jlheart.org+86 17304316969

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026